Trial · NCT03259620
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy Evaluation | CLS006 | Achieved complete clearance of all treated warts | 35 | Participants | |
| The Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy Evaluation | CLS006 Vehicle | Achieved complete clearance of all treated warts | 27 | Participants | |
| The Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy Evaluation | CLS006 | Not achieved complete clearance of all treated warts | 191 | Participants | |
| The Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts Between the Active and Vehicle at Week 18/End of Post-treatment Efficacy Evaluation | CLS006 Vehicle | Not achieved complete clearance of all treated warts | 190 | Participants | |
| The Ratio of the Number of Cleared Warts Out of the Number of Treated Warts for Each Subject | CLS006 | 0.210 | Standard Deviation 0.3771 | Ratio of Cleared Warts | |
| The Ratio of the Number of Cleared Warts Out of the Number of Treated Warts for Each Subject | CLS006 Vehicle | 0.191 | Standard Deviation 0.3500 | Ratio of Cleared Warts | |
| Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts at Week 12 | CLS006 | Complete clearance of all treated warts | 21 | Participants | |
| Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts at Week 12 | CLS006 Vehicle | Complete clearance of all treated warts | 19 | Participants | |
| Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts at Week 12 | CLS006 | Not complete clearance of all treated warts | 205 | Participants | |
| Difference in the Proportion of Subjects With Complete Clearance of All Treated Warts at Week 12 | CLS006 Vehicle | Not complete clearance of all treated warts | 198 | Participants | |
| The Ratio of the Number of Cleared Warts Out of the Number of Treated Warts for Each Subject at Week 12 | CLS006 | 0.135 | Standard Deviation 0.3112 | ratio of cleared warts | |
| The Ratio of the Number of Cleared Warts Out of the Number of Treated Warts for Each Subject at Week 12 | CLS006 Vehicle | 0.127 | Standard Deviation 0.3020 | ratio of cleared warts | |
| Change From Baseline in Wart Size for Each Subject | CLS006 | -3.5 | Standard Deviation 7.10 | mm | |
| Change From Baseline in Wart Size for Each Subject | CLS006 Vehicle | -3.1 | Standard Deviation 6.84 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03259620/results